Trisomy 18 – Definition

Trisomy 18, also called Edwards syndrome, is the second-most common constitutive chromosomal abnormality after Down syndrome.

Synonym:

Edwards syndrome

Gene:

Trisomy 18

Gen­e product:

Not applicable

Function:

Not applicable

Pattern of inheritance:

Sporadic

Prevalance:

1:6.000 – 1:8.000 live births

Genotype-phenotype correlation:

Children with mosaicism or partial trisomy 18 have a better prognosis.

Penetrance:

As far as known complete

Overview of the Chapters on This Page:

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

Trisomy 18 – Diagnosis

Diagnosis

The diagnosis is made clinically and confirmed by chromosomal analysis.

Differential Diagnoses

  • Other malformation syndromes

Clinical Presentation

Trisomy 18 is characterized by various malformations, growth retardation, developmental delay, and an intellectual disorder. In the first 5 years of life, 90% of those affected die because of heart or kidney abnormalities, eating disorders, infections, or apnea. Hepatoblastomas and Wilms tumors are the most common tumors. The risk of the latter is around 1%.

Special Features of Treatment

Treatment by a multidisciplinary team is necessary.

Diagnosis of Trisomy 18- What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Diagnosis of Trisomy 18- What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Recommendations for Early Detection in Your Patients

  • Early detection of a Wilms tumor with ultrasound, every 3 months until the age of 7
  • Early detection of hepatoblastoma with AFP and an abdominal ultrasound, every 3 months until age 4
  • Due to the poor prognosis, this is a matter of controversy and is by no means clearly indicated.

Trisomy 18 – Further Information

Open Clinical Trials/ Registries